ID

31566

Descrizione

FACBC PET/CT for Recurrent Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00562315

collegamento

https://clinicaltrials.gov/show/NCT00562315

Keywords

  1. 04/09/18 04/09/18 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

4 settembre 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Prostate Cancer NCT00562315

Eligibility Prostate Cancer NCT00562315

Criteria
Descrizione

Criteria

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients must be 18 years of age or older.
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
patients will have been originally diagnosed with localized (stage t1c, t2, or t3 ) prostate carcinoma and have undergone what was considered definitive therapy for localized disease.
Descrizione

Prostate carcinoma Localized TNM clinical staging | Definitive Treatment Localized disease

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0392752
UMLS CUI [1,3]
C3258246
UMLS CUI [2,1]
C2986592
UMLS CUI [2,2]
C0277565
in the case of brachytherapy, cryotherapy, or external beam radiation, treatment will have occurred at least 2 years in the past to eliminate patients with so-called "psa bump."
Descrizione

Brachytherapy In the past | Cold Therapy In the past | External beam radiotherapy In the past

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0006098
UMLS CUI [1,2]
C1444637
UMLS CUI [2,1]
C0010412
UMLS CUI [2,2]
C1444637
UMLS CUI [3,1]
C0419095
UMLS CUI [3,2]
C1444637
patient will have suspicion of recurrent prostate carcinoma as defined by: astro criteria of three consecutive rises of psa or earlier if clinically appropriate, and/or nadir + 2.0 after radiotherapy, and/or greater than 0.3 after prostatectomy.
Descrizione

Suspicion Prostate cancer recurrent | Raised prostate specific antigen Quantity | Nadir Post Therapeutic radiology procedure | Nadir Post Prostatectomy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0242114
UMLS CUI [1,2]
C0278838
UMLS CUI [2,1]
C0178415
UMLS CUI [2,2]
C1265611
UMLS CUI [3,1]
C1708760
UMLS CUI [3,2]
C0687676
UMLS CUI [3,3]
C1522449
UMLS CUI [4,1]
C1708760
UMLS CUI [4,2]
C0687676
UMLS CUI [4,3]
C0033573
ability to lie still for pet scanning
Descrizione

Able to lie down Quiet Positron-Emission Tomography

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0560841
UMLS CUI [1,2]
C0439654
UMLS CUI [1,3]
C0032743
patients must be able to provide written informed consent.
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
age less than 18.
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
greater than t3 disease in past
Descrizione

Disease In the past TNM clinical staging

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C1444637
UMLS CUI [1,3]
C3258246
prior prostatectomy or 2 years since brachytherapy, cryotherapy, or external beam radiation therapy.
Descrizione

Prostatectomy | Brachytherapy | Cold Therapy | External beam radiotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0033573
UMLS CUI [2]
C0006098
UMLS CUI [3]
C0010412
UMLS CUI [4]
C0419095
does not meet above criteria of suspicious psa elevation
Descrizione

Absence Raised prostate specific antigen Suspicious

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0178415
UMLS CUI [1,3]
C0750493
inability to lie still for pet scanning
Descrizione

Lacking Able to lie down Quiet | Positron-Emission Tomography

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0332268
UMLS CUI [1,2]
C0560841
UMLS CUI [1,3]
C0439654
UMLS CUI [2]
C0032743
cannot provide written informed consent.
Descrizione

Informed Consent Unable

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
bone scan findings characteristic for metastatic prostate carcinoma
Descrizione

Metastatic Prostate Carcinoma Bone scan

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0936223
UMLS CUI [1,2]
C0203668
less than 2 months since any prior prostate biopsy (to decrease false positive uptake from inflammation).
Descrizione

Biopsy of prostate Recently

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0194804
UMLS CUI [1,2]
C0332185

Similar models

Eligibility Prostate Cancer NCT00562315

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Item Group
C1512693 (UMLS CUI)
Age
Item
patients must be 18 years of age or older.
boolean
C0001779 (UMLS CUI [1])
Prostate carcinoma Localized TNM clinical staging | Definitive Treatment Localized disease
Item
patients will have been originally diagnosed with localized (stage t1c, t2, or t3 ) prostate carcinoma and have undergone what was considered definitive therapy for localized disease.
boolean
C0600139 (UMLS CUI [1,1])
C0392752 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C2986592 (UMLS CUI [2,1])
C0277565 (UMLS CUI [2,2])
Brachytherapy In the past | Cold Therapy In the past | External beam radiotherapy In the past
Item
in the case of brachytherapy, cryotherapy, or external beam radiation, treatment will have occurred at least 2 years in the past to eliminate patients with so-called "psa bump."
boolean
C0006098 (UMLS CUI [1,1])
C1444637 (UMLS CUI [1,2])
C0010412 (UMLS CUI [2,1])
C1444637 (UMLS CUI [2,2])
C0419095 (UMLS CUI [3,1])
C1444637 (UMLS CUI [3,2])
Suspicion Prostate cancer recurrent | Raised prostate specific antigen Quantity | Nadir Post Therapeutic radiology procedure | Nadir Post Prostatectomy
Item
patient will have suspicion of recurrent prostate carcinoma as defined by: astro criteria of three consecutive rises of psa or earlier if clinically appropriate, and/or nadir + 2.0 after radiotherapy, and/or greater than 0.3 after prostatectomy.
boolean
C0242114 (UMLS CUI [1,1])
C0278838 (UMLS CUI [1,2])
C0178415 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1708760 (UMLS CUI [3,1])
C0687676 (UMLS CUI [3,2])
C1522449 (UMLS CUI [3,3])
C1708760 (UMLS CUI [4,1])
C0687676 (UMLS CUI [4,2])
C0033573 (UMLS CUI [4,3])
Able to lie down Quiet Positron-Emission Tomography
Item
ability to lie still for pet scanning
boolean
C0560841 (UMLS CUI [1,1])
C0439654 (UMLS CUI [1,2])
C0032743 (UMLS CUI [1,3])
Informed Consent
Item
patients must be able to provide written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Age
Item
age less than 18.
boolean
C0001779 (UMLS CUI [1])
Disease In the past TNM clinical staging
Item
greater than t3 disease in past
boolean
C0012634 (UMLS CUI [1,1])
C1444637 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
Prostatectomy | Brachytherapy | Cold Therapy | External beam radiotherapy
Item
prior prostatectomy or 2 years since brachytherapy, cryotherapy, or external beam radiation therapy.
boolean
C0033573 (UMLS CUI [1])
C0006098 (UMLS CUI [2])
C0010412 (UMLS CUI [3])
C0419095 (UMLS CUI [4])
Absence Raised prostate specific antigen Suspicious
Item
does not meet above criteria of suspicious psa elevation
boolean
C0332197 (UMLS CUI [1,1])
C0178415 (UMLS CUI [1,2])
C0750493 (UMLS CUI [1,3])
Lacking Able to lie down Quiet | Positron-Emission Tomography
Item
inability to lie still for pet scanning
boolean
C0332268 (UMLS CUI [1,1])
C0560841 (UMLS CUI [1,2])
C0439654 (UMLS CUI [1,3])
C0032743 (UMLS CUI [2])
Informed Consent Unable
Item
cannot provide written informed consent.
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Metastatic Prostate Carcinoma Bone scan
Item
bone scan findings characteristic for metastatic prostate carcinoma
boolean
C0936223 (UMLS CUI [1,1])
C0203668 (UMLS CUI [1,2])
Biopsy of prostate Recently
Item
less than 2 months since any prior prostate biopsy (to decrease false positive uptake from inflammation).
boolean
C0194804 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial